v3.26.1
CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME - USD ($)
shares in Thousands, $ in Thousands
3 Months Ended 9 Months Ended
Mar. 31, 2026
Mar. 31, 2025
Mar. 31, 2026
Mar. 31, 2025
REVENUE:        
Total revenue $ 430,933 $ 408,160 $ 1,296,846 $ 1,181,492
OPERATING COSTS AND EXPENSES:        
Cost of commissions and other services revenue 83,268 79,412 255,403 246,283
Cost of goods sold—pharmacy revenue 171,289 162,304 569,262 448,029
Marketing and advertising 92,481 92,733 259,456 254,222
Selling, general, and administrative 38,188 41,685 112,948 122,850
Technical development 9,777 9,967 29,283 29,086
Total operating costs and expenses 395,003 386,101 1,226,352 1,100,470
INCOME FROM OPERATIONS 35,930 22,059 70,494 81,022
INTEREST EXPENSE, NET (10,602) (20,407) (34,023) (67,160)
CHANGE IN FAIR VALUE OF WARRANTS 27,489 32,986 61,821 25,344
LOSS ON EXTINGUISHMENT OF DEBT (8,659) 0 (8,659) 0
OTHER EXPENSE, NET (34) (37) (216) (70)
INCOME BEFORE INCOME TAX EXPENSE 44,124 34,601 89,417 39,136
INCOME TAX EXPENSE 3,927 8,579 10,386 4,424
NET INCOME 40,197 26,022 79,031 34,712
Senior Non-Convertible Preferred Stock accumulated dividends and accretion (18,775) (5,787) (54,382) (5,787)
NET INCOME ATTRIBUTABLE TO COMMON SHAREHOLDERS $ 21,422 $ 20,235 $ 24,649 $ 28,925
NET INCOME ATTRIBUTABLE TO COMMON SHAREHOLDERS PER SHARE:        
Basic (in dollars per share) $ 0.11 $ 0.11 $ 0.13 $ 0.17
Diluted (in dollars per share) $ 0.11 $ 0.03 $ 0.11 $ 0.13
WEIGHTED-AVERAGE COMMON STOCK OUTSTANDING USED IN PER SHARE AMOUNTS:        
Basic (in shares) 189,455 178,156 187,614 173,462
Diluted (in shares) 190,481 186,639 190,647 178,895
OTHER COMPREHENSIVE LOSS, NET OF TAX:        
Unrealized loss, net of related tax benefit for the three and nine months ended March 31, 2026, and 2025, of $0.0 million and $0.1 million $ 0 $ 0 $ 0 $ (432)
Amount reclassified into earnings, net of related tax benefit for the three months ended March 31, 2026, and 2025, of $0.0 million, and $0.0 million and for the nine months ended March 31, 2026, and 2025, of $0.0 million and $1.3 million. 0 0 0 (3,680)
OTHER COMPREHENSIVE LOSS 0 0 0 (4,112)
COMPREHENSIVE INCOME 40,197 26,022 79,031 30,600
Commissions and other services        
REVENUE:        
Total revenue 235,663 222,889 655,823 663,338
Pharmacy        
REVENUE:        
Total revenue $ 195,270 $ 185,271 $ 641,023 $ 518,154